No abstract available
Keywords:
AML; Hypomethylating agent; IDH1; IDH2; Toxicity; Venetoclax.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
-
Research Support, N.I.H., Extramural
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Azacitidine* / therapeutic use
-
Bridged Bicyclo Compounds, Heterocyclic / therapeutic use
-
Decitabine / therapeutic use
-
Humans
-
Leukemia, Myeloid, Acute* / drug therapy
Substances
-
Azacitidine
-
Decitabine
-
venetoclax
-
Bridged Bicyclo Compounds, Heterocyclic